Skip to main navigation
Skip to search
Skip to main content
WashU Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Research Profiles
Home
Profiles
Research units
Research output
Posttherapy surveillance monitoring of cervical cancer by FDG-PET
Perry W. Grigsby
,
Barry A. Siegel
,
Farrokh Dehdashti
,
David G. Mutch
Institute of Clinical and Translational Sciences (ICTS)
Siteman Cancer Center
Division of Nuclear Medicine
Division of Gynecologic Oncology
Department of Radiology
Research output
:
Contribution to journal
›
Article
›
peer-review
106
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Posttherapy surveillance monitoring of cervical cancer by FDG-PET'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cervical Cancer
100%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
100%
Fluorodeoxyglucose Uptake
100%
Surveillance Monitoring
100%
Cervical Carcinoma
80%
Prognostic Factors
40%
Positron Emission Tomography/computed Tomography (PET/CT)
40%
Whole-body
20%
Progression-free Survival
20%
Multivariate Analysis
20%
Initial Treatment
20%
Retrospective Review
20%
18F-fluorodeoxyglucose (18F-FDG)
20%
Survivors
20%
Lymph Node Metastasis
20%
Cervix
20%
Irradiation
20%
Radiation Effects
20%
New Diagnosis
20%
Para-aortic Lymph Node
20%
Supraclavicular Lymph Node
20%
Pelvic Lymph Nodes
20%
Tumor Uptake
20%
Chemotherapy Effect
20%
Glucose Analogs
20%
Medicine and Dentistry
Positron Emission Tomography
100%
Cervical Cancer
100%
Fluorodeoxyglucose
100%
Carcinoma
20%
Uterine Cervix Carcinoma
20%
Prognostic Factor
20%
Uterine Cervix
20%
Neoplasm
10%
Progression Free Survival
10%
Survival Rate
10%
Pelvis
10%
Lymph Node
10%
Lymph Node Metastasis
10%
Fluorodeoxyglucose F 18
10%
Cervix
10%
Paraaortic Lymph Node
10%
Supraclavicular Lymph Node
10%
Glucose Derivative
10%
Sphingolipid Activator Protein 2
10%
Chemotherapy
10%
Multivariate Analysis
10%